US HB2003 | 2013-2014 | 113th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 17-1)
Status: Introduced on May 15 2013 - 25% progression, died in committee
Action: 2013-05-17 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Gluten in Medicine Disclosure Act of 2013 - Amends the Federal Food, Drug, and Cosmetic Act to deem to be misbranded any drug intended for human use that contains an ingredient (other than a polyol) that constitutes or is derived from a grain or starch-containing ingredient and whose label fails to include a parenthetical statement identifying the source of the ingredient so constituted or derived.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Gluten in Medicine Disclosure Act of 2013

Sponsors


History

DateChamberAction
2013-05-17HouseReferred to the Subcommittee on Health.
2013-05-15HouseReferred to the House Committee on Energy and Commerce.

Same As/Similar To

HB5559 (Related) 2014-09-19 - Sponsor introductory remarks on measure. (CR E1496)

Subjects


US Congress State Sources


Bill Comments

feedback